Biosimilars: Transforming Patient Care in Oncology and Immunology
By Dara Shahrokh Ph.D., Medical Advisor, Pharmaceuticals The introduction of biosimilars has represented a significant leap forward in the global
Read moreBy Dara Shahrokh Ph.D., Medical Advisor, Pharmaceuticals The introduction of biosimilars has represented a significant leap forward in the global
Read moreBy Melissa Morgan, Director of Patient Experience, Optima Dermatology The healthcare industry has traditionally seen patients through a clinical lens,
Read moreBy Chandler Jones, MSHA, RRT, RRT-ACCS, RRT-NPS, CPFT, PDE, Pulmonary Disease Navigator – Novant Health | Adjunct Faculty, Respiratory Therapy
Read moreBy Evan T. Keller DVM, PhD, Director Single Cell Spatial Analysis Program and Biointerfaces Institute, University of Michigan, Ann Arbor,
Read moreBy Reed A. Omary, MD, MS Carol D. & Henry P. Pendergrass Professor of Radiology & Biomedical Engineering, Vanderbilt University;
Read more